KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $91.3 billion.

  • Medtronic's Liabilities and Shareholders Equity rose 144.82% to $91.3 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $364.0 billion, marking a year-over-year increase of 93.26%. This contributed to the annual value of $91.7 billion for FY2025, which is 188.82% up from last year.
  • As of Q4 2025, Medtronic's Liabilities and Shareholders Equity stood at $91.3 billion, which was up 144.82% from $91.0 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Liabilities and Shareholders Equity registered a high of $97.3 billion during Q1 2021, and its lowest value of $89.7 billion during Q3 2024.
  • For the 5-year period, Medtronic's Liabilities and Shareholders Equity averaged around $91.5 billion, with its median value being $91.0 billion (2022).
  • As far as peak fluctuations go, Medtronic's Liabilities and Shareholders Equity surged by 479.2% in 2021, and later plummeted by 561.94% in 2022.
  • Quarter analysis of 5 years shows Medtronic's Liabilities and Shareholders Equity stood at $91.8 billion in 2021, then rose by 1.62% to $93.2 billion in 2022, then dropped by 3.38% to $90.1 billion in 2023, then dropped by 0.05% to $90.0 billion in 2024, then grew by 1.45% to $91.3 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $91.3 billion for Q4 2025, versus $91.0 billion for Q3 2025 and $91.7 billion for Q2 2025.